{"id":"https://openalex.org/W1970036342","doi":"https://doi.org/10.1089/cap.2005.15.331","title":"Atomoxetine Use Associated with Onset of a Motor Tic","display_name":"Atomoxetine Use Associated with Onset of a Motor Tic","publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W1970036342","doi":"https://doi.org/10.1089/cap.2005.15.331","mag":"1970036342","pmid":"https://pubmed.ncbi.nlm.nih.gov/15910218"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2005.15.331","doi":"https://doi.org/10.1089/cap.2005.15.331","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2005.15.331","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029331272","display_name":"Marcialee Ledbetter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738079","display_name":"University of Oklahoma - Tulsa","ror":"https://ror.org/04g1a0w27","country_code":"US","type":"education","lineage":["https://openalex.org/I4392738079","https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marcialee Ledbetter","raw_affiliation_strings":["Departments of Psychiatry and Pediatrics, University of Oklahoma\u2014Tulsa, Tulsa, Oklahoma","Department of Psychiatry and Pediatrics, University of Oklahoma-Tulsa, Tulsa, Oklahoma 74135, USA. Marcialee-Ledbetter@ouhsc.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and Pediatrics, University of Oklahoma\u2014Tulsa, Tulsa, Oklahoma","institution_ids":["https://openalex.org/I4392738079"]},{"raw_affiliation_string":"Department of Psychiatry and Pediatrics, University of Oklahoma-Tulsa, Tulsa, Oklahoma 74135, USA. Marcialee-Ledbetter@ouhsc.edu","institution_ids":["https://openalex.org/I4392738079"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5029331272"],"corresponding_institution_ids":["https://openalex.org/I4392738079"],"apc_list":null,"apc_paid":null,"fwci":1.8441,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.83469124,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"15","issue":"2","first_page":"331","last_page":"333"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.10920000076293945,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12684","display_name":"Stuttering Research and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/tourette-syndrome","display_name":"Tourette syndrome","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tic-disorders","display_name":"tic disorders","score":0.9459999799728394},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9850000143051147},{"id":"https://openalex.org/keywords/selective-norepinephrine-reuptake-inhibitors","display_name":"selective norepinephrine reuptake inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.7730000019073486},{"id":"https://openalex.org/keywords/adhd-medication","display_name":"ADHD medication","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9882981777191162},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.9010260105133057},{"id":"https://openalex.org/C2776681478","wikidata":"https://www.wikidata.org/wiki/Q1077139","display_name":"Tic disorder","level":3,"score":0.8056338429450989},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.5571016073226929},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5540079474449158},{"id":"https://openalex.org/C2777200579","wikidata":"https://www.wikidata.org/wiki/Q738538","display_name":"Tics","level":2,"score":0.5134552121162415},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5088306069374084},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.5031234622001648},{"id":"https://openalex.org/C2777026814","wikidata":"https://www.wikidata.org/wiki/Q191779","display_name":"Tourette syndrome","level":2,"score":0.4533032178878784},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.42555907368659973},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.42088085412979126},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3931429088115692},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.28919094800949097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2071111798286438},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013981","descriptor_name":"Tic Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013981","descriptor_name":"Tic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D020323","descriptor_name":"Tics","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D020323","descriptor_name":"Tics","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/cap.2005.15.331","doi":"https://doi.org/10.1089/cap.2005.15.331","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2005.15.331","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:15910218","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15910218","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1991549050","https://openalex.org/W2068852148","https://openalex.org/W2069028392","https://openalex.org/W2083338868","https://openalex.org/W2106230318","https://openalex.org/W2119599154","https://openalex.org/W2123980944","https://openalex.org/W2266471137","https://openalex.org/W4235738764"],"related_works":["https://openalex.org/W2195123592","https://openalex.org/W2067530758","https://openalex.org/W2560606377","https://openalex.org/W1965070231","https://openalex.org/W1599925494","https://openalex.org/W4220883720","https://openalex.org/W2128074636","https://openalex.org/W1995484354","https://openalex.org/W2082719588","https://openalex.org/W2387480759"],"abstract_inverted_index":{"Patients":[0],"with":[1,23,48,71,93],"attention-deficit/hyperactivity":[2],"disorder":[3],"(ADHD)":[4],"are":[5],"at":[6],"increased":[7],"risk":[8],"for":[9,46],"Tourette's":[10],"Disorder":[11],"and":[12,18,50,95],"other":[13],"tic":[14,30,53,68,98],"disorders.":[15],"Stimulant":[16],"medications":[17],"bupropion":[19],"have":[20],"been":[21,39],"associated":[22,70],"the":[24,63,75],"onset":[25,64],"or":[26],"exacerbation":[27],"of":[28,65,74],"a":[29,51,58,66,72,96],"disorder.":[31,54,99],"The":[32],"selective":[33],"norepinephrine":[34],"reuptake":[35],"inhibitor,":[36],"atomoxetine,":[37],"has":[38],"proposed":[40],"to":[41,82],"be":[42],"an":[43,87],"alternative":[44,89],"medication":[45,76,90],"patients":[47,92],"ADHD":[49,94],"comorbid":[52,97],"This":[55],"paper":[56],"reviews":[57],"case":[59],"study":[60],"in":[61,91],"which":[62],"motor":[67],"was":[69],"trial":[73],"atomoxetine.":[77],"Further":[78],"research":[79],"is":[80,86],"needed":[81],"determine":[83],"if":[84],"atomoxetine":[85],"appropriate":[88]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}